Exalt D Single-use Duodenoscope in ERCP Procedures in China

Cholangiopancreatography Clinical Trial

— ExaltDScope  

Official title:

Real World Study of Exalt D Single-use Duodenoscope in ERCP Procedures in China

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04687774
• Other study ID #: E7164
• Status: Withdrawn
• Phase: N/A
• Start date: August 2022
• Est. completion date: October 2022

Study information

• Verified date: June 2024
• Source: Boston Scientific Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Study Objective(s)：This study is to evaluate the feasibility, preliminary safety and performance of Exalt D Single-use Duodenoscope in ERCP procedures in China, to generate local real world data from a Chinese ERCP population.

Study Design：Prospective, single-arm study Planned Number of Subjects：Up to 35 to satisfy 30 treated cohort Primary Endpoint：Ability to complete the ERCP procedure for the intended indication(s) without crossing to reusable duodenoscope.

It is also considered as Exalt D's ability if the clinical effect is the same per the investigator's judgement in case of an endoscope change (non-Exalt D).

Description:

Device Description：The Exalt™ Model D Single-Use Duodenoscope is a sterile, single-use endoscope that facilitates access to the duodenum, delivery of accessories, and live video when connected to an Exalt™ Controller.

The Exalt™ Controller is an electronic device that:

• Receives video signals from a Boston Scientific single-use endoscope,

• Processes the video signals,

• Outputs video images to a video monitor, and

• Outputs electrical signal(s) that interface with external image capture systems.

Study Design：This is a prospective, single-arm study with up to 35 subjects to satisfy 30 treated cohort in up to 3 centers. The study duration is expected to be approximately 7 months, assuming 6 months enrollment and 1 month follow up. The study duration for each subject is expected to be approximately 30 days.

Data Analyses：All statistical analyses will be done using The SAS System software, version 8 or higher (Copyright © 2000 SAS Institute Inc., SAS Campus Drive, Cary, North Carolina 27513, USA. All rights reserved).

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: October 2022
• Est. primary completion date: September 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. 18 years or older

2. Willing and able to comply with the study procedures and provide written informed consent to participate in the study

3. Schedule for a clinically indicated ERCP

Exclusion Criteria:

1. Potentially vulnerable subjects, including, but not limited to pregnant women

2. Subjects for whom endoscopic techniques are contraindicated

3. Subjects who are currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor

4. Investigator discretion

Related Conditions & MeSH terms

• Cholangiopancreatography

Intervention

Device:
• ExaltTM Model D Single-Use Duodenoscope
The Exalt™ Model D Single-Use Duodenoscope is a sterile, single-use endoscope that facilitates access to the duodenum, delivery of accessories, and live video when connected to an Exalt™ Controller.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Boston Scientific Corporation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients complete the ERCP procedure	Ability to complete the ERCP procedure for the intended indication(s) without crossing to reusable duodenoscope.; It is also considered as Exalt D's ability if the clinical effect is the same per the investigator's judgement in case of an endoscope change (non-Exalt D).	During the procedure
Secondary	Endoscopist qualitative rating	Endoscopist rating of the Exalt single-use duodenoscope compared to their past experience with marketed reusable duodenoscopes as it pertains to various design and performance related attributes. Besides those criteria similar to Exalt DScope 01 study, assessment in this study will include imaging quality (brightness, color, photometry), overall maneuverability and overall satisfaction, which will be rated from 1-10, where 1 is the worst and 10 is the best.	During the procedure